Login / Signup

Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide study.

Nikolai Dyrberg LoftAlexander EgebergM K RasmussenL E BryldC V NissenT N DamK K AjgeiyL IversenLone Skov
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
A small proportion of patients with psoriasis treated with biologics are either super-responders or treatment refractory. Treatment refractory patients have higher body weight, whereas super-responders have fewer comorbidities and higher socioeconomic status.
Keyphrases
  • body weight
  • rheumatoid arthritis
  • newly diagnosed
  • risk factors
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • smoking cessation
  • patient reported